Story detail view · 2026-07
US health panel recommends easing restrictions on controversial peptides

US health panel recommends easing restrictions on controversial peptides

Quick Summary

Vote from advisory group – whose members include people linked to peptides industry – likely to embolden RFK Jr A panel of federal health advisers on Thursday narrowly recommended easing access to several peptides popular with wellness influencers and celebrities, despite warnings from government scientists that the chemicals have not been shown to be safe or effective. In a series of votes, outside experts to the Food and Drug Administration advised the agency to drop current restrictions barring pharmacies from producing injectable peptides with names like BPC-157, TB-500 and KPV. Continue reading...

Continue Reading on The Guardian World

Get instant updates on Telegram

Join our channel to receive the latest headlines and breaking stories as soon as they are published.

Join channel

Comments (0)

Join the conversation. Comments are rate-limited, secured, and GDPR-compliant.

No comments yet. Be the first to share your thoughts!

Write a comment

0 / 500